These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2897239

  • 1. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A, Sugano M, Nakashima Y, Tasaki H, Kuroiwa A.
    Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J, Koga S, Uzawa H, Arakawa K.
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
    [Abstract] [Full Text] [Related]

  • 3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Aug; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 4. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T, Shirai K, Shinomiya M, Ishikawa Y, Murano S, Morisaki N, Saito Y, Yoshida S, Sasaki N.
    Clin Ther; 1989 Aug; 11(6):820-7. PubMed ID: 2692824
    [Abstract] [Full Text] [Related]

  • 5. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P, Celis H, Desager JP, Fagard R.
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [Abstract] [Full Text] [Related]

  • 6. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989 Jul; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 7. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
    Sasaki N, Saito Y, Shinomiya M, Kanzaki T, Ishikawa Y, Mori S, Kobayashi J, Murano S, Nishide T, Morisaki N.
    Clin Ther; 1990 Jul; 12(2):157-64. PubMed ID: 2354485
    [Abstract] [Full Text] [Related]

  • 8. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K, Ying H, Arakawa K.
    Clin Ther; 1990 Jul; 12(2):132-8. PubMed ID: 2354482
    [Abstract] [Full Text] [Related]

  • 9. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

  • 10. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 11. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW, Khokhar AM, Flax JS.
    J Cardiovasc Pharmacol; 1982 Feb; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [Abstract] [Full Text] [Related]

  • 12. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
    Gemma G, Montanari G, Suppa G, Paralovo A, Franceschini G, Mantero O, Sirtori CR.
    J Cardiovasc Pharmacol; 1982 Feb; 4 Suppl 2():S233-7. PubMed ID: 6177963
    [Abstract] [Full Text] [Related]

  • 13. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E, Rodríguez-López CM, Cano MD, Peña-Bernal M.
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [Abstract] [Full Text] [Related]

  • 14. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
    Murai A, Miyahara T, Tanaka T, Sako Y, Nishimura N, Kameyama M.
    Artery; 1985 Nov; 12(4):234-43. PubMed ID: 3935096
    [Abstract] [Full Text] [Related]

  • 15. Lipid profile improvement following celiprolol.
    Herrmann JM, von Heyman F, Freischütz G.
    J Int Med Res; 1988 Nov; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [Abstract] [Full Text] [Related]

  • 16. Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
    Sasaki J, Arakawa K.
    Clin Ther; 1989 Nov; 11(1):129-34. PubMed ID: 2655902
    [Abstract] [Full Text] [Related]

  • 17. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Mar; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E.
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [Abstract] [Full Text] [Related]

  • 20. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.
    Kurowska EM, Jordan J, Spence JD, Wetmore S, Piché LA, Radzikowski M, Dandona P, Carroll KK.
    Clin Invest Med; 1997 Jun; 20(3):162-70. PubMed ID: 9189647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.